Prevalence and clinical outcomes of fibrotic interstitial lung disease in ANCA associated vasculitis: a single-centre, retrospective, cohort study. [PDF]
Tirelli C +12 more
europepmc +1 more source
Correction: Efficacy and safety of avacopan in the treatment of ANCA-associated vasculitis: a systematic review and meta-analysis. [PDF]
Aldhuaina K, Alghanim K.
europepmc +1 more source
Treatment With Avacopan in ANCA-Associated Vasculitis With Kidney Involvement. [PDF]
Geetha D +10 more
europepmc +1 more source
Cytomegalovirus-induced severe enterocolitis associated with ANCA-associated vasculitis and diffuse alveolar haemorrhage in a child: a diagnostic and therapeutic dilemma. [PDF]
Ma D +7 more
europepmc +1 more source
ANCA-associated vasculitis combined with coexisting Aspergillus fumigatus and Mycobacterium avium complex infections: a case report. [PDF]
Li X +5 more
europepmc +1 more source
Aromatase Inhibitor-Related Alveolar Hemorrhage or ANCA-Associated Vasculitis? [PDF]
Büyükavcı R.
europepmc +1 more source
Manganese-loaded carbon nanoparticles ameliorate ANCA-associated vasculitis by inhibiting ferroptosis. [PDF]
Wang Y +6 more
europepmc +1 more source
ANCA-associated vasculitis is associated with an increased risk of cardiac and vascular morbidity: results of a large-scale propensity-matched global retrospective cohort study. [PDF]
Klapa S +14 more
europepmc +1 more source

